Ann: AGM Chairman address and CEO presentation, page-32

First 32 Last

Share
Profile

Follow
jwoody1000

5,229 Posts.

584

20/11/20

13:39

Post #: 49020551
Share

Originally posted by col69: ↑

No @antibotter ... my very specific question wasn't answered !

Just because the license is valid until 2030 and JF says that ITF Pharma are not walking away doesn't answer the question I 'specifically' asked ...... business is built on contractual agreements, not the CEO's say so that they aren't walking away !

My question:

Is there a clause in the ITF license agreement that allows ITF Pharma to walk away if after a certain time frame (say) 2 or 3 years if the Vivagel BV product has not been approved by the FDA and there is no ability for ITF Pharma to sell and distribute the product within the USA ?

If there is an ability for ITF to exit the deal through non performance or non delivery of an FDA approved product to distribute it is a big deal IMO because once that time line has expired (assuming it exists) the deal could become useless through a simple letter from their lawyer..... how long do you honestly think they will wait, certainly not anywhere near 2030 IMO ?

Lawyers rely on clauses in contractual agreements to enable their clients to do things like 'walk away' from deals that have gone nowhere, not the assurance of a our CEO - just sayin' and so again I re-iterate my question did not get answered.

Expand

did anyone raise queries about who they are marketing to,
I saw on reply about the Airlines and travel, which is one of the queries i sent via email.
but a bigger more focused one.. which would have hit front page new around the world is have the approached the world (japan of course) Oylmpic Committees. ...being part of an Olympics threshold protocol for prevention, protection, and treatment to de-risk the again cancelling of the Olympics, or at least MOU pending

SPL Price at posting: $1.40 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

What's causing the cost-of-living crisis, and how to navigate it

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%